Xiaobo Miao
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Retraction: Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.
Journal: Oncotarget
Published: April 24, 2026
Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation.
Journal: Frontiers in oncology
Published: April 08, 2022
Knockdown of lncRNA ZFAS1-suppressed non-small cell lung cancer progression via targeting the miR-150-5p/HMGA2 signaling.
Journal: Journal of cellular biochemistry
Published: June 27, 2019
MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 17, 2018
LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis.
Journal: International journal of biological macromolecules
Published: February 06, 2018
The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing.
Journal: OncoTargets and therapy
Published: February 03, 2018
Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
Journal: International journal of biological macromolecules
Published: January 22, 2017
Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.
Journal: Oncotarget
Published: July 04, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026